| Current Price | $1.21 | Mkt Cap | $107.7M |
|---|---|---|---|
| Open | $1.22 | P/E Ratio | 0.00 |
| Prev. Close | $1.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.20 - $1.24 | Volume | 833,372 |
| 52-Wk Range | $1.20 - $5.39 | Avg. Daily Vol. | 795,824 |
| Current Price | $1.21 | Mkt Cap | $107.7M |
|---|---|---|---|
| Open | $1.22 | P/E Ratio | 0.00 |
| Prev. Close | $1.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.20 - $1.24 | Volume | 833,372 |
| 52-Wk Range | $1.20 - $5.39 | Avg. Daily Vol. | 795,824 |
The best Bull and Bear pitches based on recency and number of recommendations.
It's hard to get enthusiastic about Chimerix but I've done pretty well on this stock both long and short, on CAPS and in real life. Right now my instincts are telling me the stock is oversold and brincidofovir is not dead. Market cap is 210M, cash is… More
Chimerix is ripping of late and I smell a rat. The stock was ailing in May even after the company solved their compassionate use PR nightmare, and management found the exact bottom of the stock to price a huge dilutive financing of 112M. Since then… More
Read the most recent pitches from players about CMRX.
Recs
oscillation
(73.12)
Submitted: 5/21/2016 9:12:46 AM :
Start Price:
$4.72
NASDAQ:CMRX Score:
-167.29
nev
Recs
zzlangerhans
(99.73)
Submitted: 5/19/2016 3:42:56 PM :
Start Price:
$4.55
NASDAQ:CMRX Score:
-168.04
It's hard to get enthusiastic about Chimerix but I've done pretty well on this stock both long and short, on CAPS and in real life. Right now my instincts are telling me the stock is oversold and brincidofovir is not dead. Market cap is 210M, cash is 315M, no debt, and burn was 26M last quarter. Cash won't decline to the current market cap for a year. 36 week final data from the AdVise trial will be released in about three months and probably won't be worse than the 24 week data, possibly better. The smallpox indication is still alive and a second animal study will be performed later this year. Trials of iv brincidofovir will begin in Q3.
I just bought 2000 shares at 4.57. Unlike my previous trade which I closed for relatively small gains, I'll probably double down on this if the share price stays low over the next couple of weeks but doesn't totally tank.
Recs
3barns
(< 20)
Submitted: 10/3/2014 10:07:15 AM :
Start Price:
$30.46
NASDAQ:CMRX Score:
+198.01
CFO selling his stock
Find the members with the highest scoring picks in CMRX.
BadPowerScore (< 20) Score: +225.66
The Score Leader is the player with the highest score across all their picks in CMRX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| BadPowerScore | < 20 | 9/17/2013 |
|
5Y | $19.68 | -93.85% | +131.81% | +225.66 | 0 Comment | |
| 3barns | < 20 | 10/3/2014 |
|
5Y | $30.46 | -96.03% | +101.98% | +198.01 | 1 Comment | |
| Slickrick9565 | 38.24 | 1/7/2016 |
|
5Y | $8.78 | -86.22% | +102.98% | +189.20 | 0 Comment | |
| chushogi | 63.70 | 11/7/2016 |
|
5Y | $3.75 | -67.73% | +87.51% | +155.24 | 0 Comment | |
| Trumpace | < 20 | 10/13/2020 |
|
5Y | $2.96 | -59.12% | +12.87% | -71.99 | 0 Comment | |
| drugtrader | 57.56 | 5/1/2020 |
|
5Y | $2.10 | -42.38% | +39.00% | -81.38 | 0 Comment | |
| portefeuille | 98.20 | 4/29/2019 |
|
5Y | $2.53 | -52.17% | +35.08% | -87.26 | 0 Comment | |
| portefeuille2 | 98.71 | 4/29/2019 |
|
5Y | $2.53 | -52.17% | +35.08% | -87.26 | 0 Comment | |
| karakartal | < 20 | 7/6/2020 |
|
5Y | $3.20 | -62.19% | +25.30% | -87.49 | 0 Comment | |
| foggs1 | 66.55 | 3/24/2021 |
|
5Y | $9.41 | -87.14% | +1.40% | -88.55 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
